日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transcriptomics analysis reveals distinct mechanism of breast cancer stem cells regulation in mammospheres from MCF-7 and T47D cells

转录组学分析揭示乳腺癌干细胞在乳球中与 MCF-7 和 T47D 细胞的不同调控机制

Adam Hermawan, Herwandhani Putri, Nurul Fatimah, Heri Himawan Prasetio

Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer

硼载体五肽-硼烷-0-醇的合成及用于乳腺癌硼中子俘获治疗的细胞毒性

Rohmad Yudi Utomo, Febri Wulandari, Dhania Novitasari, Ratna Asmah Susidarti, Mitsunori Kirihata, Adam Hermawan, Edy Meiyanto

Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies

通过生物信息学和体外研究鉴定柚皮素在乳腺癌干细胞抑制中的潜在治疗靶点

Adam Hermawan, Muthi Ikawati, Riris Istighfari Jenie, Annisa Khumaira, Herwandhani Putri, Ika Putri Nurhayati, Sonia Meta Angraini, Haruma Anggraini Muflikhasari

A proteomic analysis of chemoresistance development via sequential treatment with doxorubicin reveals novel players in MCF‑7 breast cancer cells

通过对阿霉素序贯治疗产生化学耐药性的蛋白质组学分析,揭示了 MCF-7 乳腺癌细胞中的新参与者

Ann-Katrin Sommer, Adam Hermawan, Bojan Ljepoja, Thomas Fröhlich, Georg J Arnold, Ernst Wagner, Andreas Roidl

Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases

盐霉素联合治疗通过促进受体酪氨酸激酶的溶酶体降解增强他莫昔芬在管腔 A 乳腺肿瘤细胞中的细胞毒性

Ann-Katrin Sommer, Adam Hermawan, Frauke Martina Mickler, Bojan Ljepoja, Pjotr Knyazev, Christoph Bräuchle, Axel Ullrich, Ernst Wagner, Andreas Roidl

Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells

连续盐霉素治疗通过上皮样肿瘤细胞的克隆选择导致耐药性的形成

Florian Kopp, Adam Hermawan, Prajakta Shirish Oak, Vijay Kumar Ulaganathan, Annika Herrmann, Nefertiti Elnikhely, Chitra Thakur, Zhiguang Xiao, Pjotr Knyazev, Beyhan Ataseven, Rajkumar Savai, Ernst Wagner, Andreas Roidl